<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15308723</PMID><DateCompleted><Year>2004</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>78</Volume><Issue>17</Issue><PubDate><Year>2004</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.</ArticleTitle><Pagination><StartPage>9285</StartPage><EndPage>9294</EndPage><MedlinePgn>9285-94</MedlinePgn></Pagination><Abstract><AbstractText>The induction of alpha/beta interferon (IFN-alpha/beta) is a powerful host defense mechanism against viral infection, and many viruses have evolved strategies to overcome the antiviral effects of IFN. In this study, we found that IFN-alpha had only some degree of antiviral activity against Japanese encephalitis virus (JEV) infection, in contrast to another flavivirus, dengue virus serotype 2, which was highly sensitive to IFN-alpha in the cultured cell system. JEV infection appeared to render cells resistant to IFN-alpha since the IFN-alpha-induced luciferase reporter activity driven by the IFN-stimulated response element (ISRE) was gradually reduced as the JEV infection progressed. Since the biological activities of IFNs are triggered by the Janus kinase (Jak) signal transducer and activation of transcription (Stat) signaling cascade, we then studied the activation of Jak-Stat pathway in the virus-infected cells. The IFN-alpha-stimulated tyrosine phosphorylation of Stat1, Stat2, and Stat3 was suppressed by JEV in a virus replication and de novo protein synthesis-dependent manner. Furthermore, JEV infection blocked the tyrosine phosphorylation of IFN receptor-associated Jak kinase, Tyk2, without affecting the expression of IFN-alpha/beta receptor on the cell surface. Consequently, expression of several IFN-stimulated genes in response to IFN-alpha stimulation was also reduced in the JEV-infected cells. Overall, our findings suggest that JEV counteracts the effect of IFN-alpha/beta by blocking Tyk2 activation, thereby resulting in inhibition of Jak-Stat signaling pathway.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ren-Jye</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Ching-Len</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Elong</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017471">Receptors, Interferon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050794">STAT1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494079">STAT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>156986-95-7</RegistryNumber><NameOfSubstance UI="D053633">Receptor, Interferon alpha-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>21820-51-9</RegistryNumber><NameOfSubstance UI="D019000">Phosphotyrosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="C507904">JAK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D053613">Janus Kinase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004664" MajorTopicYN="N">Encephalitis Virus, Japanese</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053613" MajorTopicYN="N">Janus Kinase 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019000" MajorTopicYN="N">Phosphotyrosine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="N">Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053633" MajorTopicYN="N">Receptor, Interferon alpha-beta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017471" MajorTopicYN="N">Receptors, Interferon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050794" MajorTopicYN="N">STAT1 Transcription Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>17</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>9</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>17</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15308723</ArticleId><ArticleId IdType="pmc">PMC506928</ArticleId><ArticleId IdType="doi">10.1128/JVI.78.17.9285-9294.2004</ArticleId><ArticleId IdType="pii">78/17/9285</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adler, B., H. Adler, H. Pfister, T. W. Jungi, and E. Peterhans. 1997. Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis. J. Virol. 71:3255-3258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191459</ArticleId><ArticleId IdType="pubmed">9060690</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, W. S. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2:410-416.</Citation><ArticleIdList><ArticleId IdType="pubmed">12093007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D. M. Livingston. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383:344-347.</Citation><ArticleIdList><ArticleId IdType="pubmed">8848048</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke, D. S., and T. P. Monath. 2001. Flaviviruses, p. 1043-1125. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott/The Williams &amp; Wilkins Co., Philadelphia, Pa.</Citation></Reference><Reference><Citation>Burke, D. S., and J. C. Morill. 1987. Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J. Infect. Dis. 155:797-799.</Citation><ArticleIdList><ArticleId IdType="pubmed">3029244</ArticleId></ArticleIdList></Reference><Reference><Citation>Charleston, B., L. S. Brackenbury, B. V. Carr, M. D. Fray, J. C. Hope, C. J. Howard, and W. I. Morrison. 2002. Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo. J. Virol. 76:923-927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136826</ArticleId><ArticleId IdType="pubmed">11752182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. K., C. L. Liao, C. G. Lin, S. C. Lai, C. I. Liu, S. H. Ma, Y. Y. Huang, and Y. L. Lin. 1996. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology 217:220-229.</Citation><ArticleIdList><ArticleId IdType="pubmed">8599206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. K., Y. L. Lin, C. L. Liao, C. G. Lin, Y. L. Huang, C. T. Yeh, S. C. Lai, J. T. Jan, and C. Chin. 1996. Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro. Virology 223:79-88.</Citation><ArticleIdList><ArticleId IdType="pubmed">8806542</ArticleId></ArticleIdList></Reference><Reference><Citation>Colamonici, O. R., P. Domanski, S. M. Sweitzer, A. Larner, and R. M. Buller. 1995. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J. Biol. Chem. 270:15974-15978.</Citation><ArticleIdList><ArticleId IdType="pubmed">7608155</ArticleId></ArticleIdList></Reference><Reference><Citation>Crance, J. M., N. Scaramozzino, A. Jouan, and D. Garin. 2003. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antivir. Res. 58:73-79.</Citation><ArticleIdList><ArticleId IdType="pubmed">12719009</ArticleId></ArticleIdList></Reference><Reference><Citation>Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28094</ArticleId><ArticleId IdType="pubmed">9861020</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond, M. S., and E. Harris. 2001. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 289:297-311.</Citation><ArticleIdList><ArticleId IdType="pubmed">11689052</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond, M. S., T. G. Roberts, D. Edgil, B. Lu, J. Ernst, and E. Harris. 2000. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol. 74:4957-4966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110847</ArticleId><ArticleId IdType="pubmed">10799569</ArticleId></ArticleIdList></Reference><Reference><Citation>Didcock, L., D. F. Young, S. Goodbourn, and R. E. Randall. 1999. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73:9928-9933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113042</ArticleId><ArticleId IdType="pubmed">10559305</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Sastre, A. 2002. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect. 4:647-655.</Citation><ArticleIdList><ArticleId IdType="pubmed">12048034</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcin, D., P. Latorre, and D. Kolakofsky. 1999. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73:6559-6565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112739</ArticleId><ArticleId IdType="pubmed">10400752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh, S. N., M. K. Goverdhan, P. S. Sathe, S. C. Chelliah, S. V. Naik, P. V. Godbole, and K. Banerjee. 1990. Protective effect of 6-MFA, a fungal interferon inducer against Japanese encephalitis virus in bonnet macaques. Indian J. Med. Res. 91:408-413.</Citation><ArticleIdList><ArticleId IdType="pubmed">1965430</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81:2341-2364.</Citation><ArticleIdList><ArticleId IdType="pubmed">10993923</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotoh, B., T. Komatsu, K. Takeuchi, and J. Yokoo. 2002. Paramyxovirus strategies for evading the interferon response. Rev. Med. Virol. 12:337-357.</Citation><ArticleIdList><ArticleId IdType="pubmed">12410527</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotoh, B., K. Takeuchi, T. Komatsu, J. Yokoo, Y. Kimura, A. Kurotani, A. Kato, and Y. Nagai. 1999. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett. 459:205-210.</Citation><ArticleIdList><ArticleId IdType="pubmed">10518019</ArticleId></ArticleIdList></Reference><Reference><Citation>Harcourt, B. H., A. Sanchez, and M. K. Offermann. 1999. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1&#x3b2;, in endothelial cells. J. Virol. 73:3491-3496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104118</ArticleId><ArticleId IdType="pubmed">10074208</ArticleId></ArticleIdList></Reference><Reference><Citation>Harinasuta, C., C. Wasi, and S. Vithanomsat. 1984. The effect of interferon on Japanese encephalitis virus in vitro. Southeast Asian J. Trop. Med. Public Health. 15:564-568.</Citation><ArticleIdList><ArticleId IdType="pubmed">6535269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa, H., Y. Satake, and Y. Kobayashi. 1990. Effect of cytokines on Japanese encephalitis virus production by human monocytes. Microbiol. Immunol. 34:459-466.</Citation><ArticleIdList><ArticleId IdType="pubmed">2118221</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim, M. H., D. Moradpour, and H. E. Blum. 1999. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73:8469-8475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112866</ArticleId><ArticleId IdType="pubmed">10482599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho, L. J., J. J. Wang, M. F. Shaio, C. L. Kao, D. M. Chang, S. W. Han, and J. H. Lai. 2001. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166:1499-1506.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, A. J., and J. T. Roehrig. 1999. New mouse model for dengue virus vaccine testing. J. Virol. 73:783-786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC103889</ArticleId><ArticleId IdType="pubmed">9847388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalvakolanu, D. V., S. K. Bandyopadhyay, M. L. Harter, and G. C. Sen. 1991. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88:7459-7463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC52319</ArticleId><ArticleId IdType="pubmed">1652751</ArticleId></ArticleIdList></Reference><Reference><Citation>Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.</Citation><ArticleIdList><ArticleId IdType="pubmed">12209136</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu, T., K. Takeuchi, J. Yokoo, Y. Tanaka, and B. Gotoh. 2000. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. J. Virol. 74:2477-2480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111735</ArticleId><ArticleId IdType="pubmed">10666284</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs, D. L., and D. J. Hilton. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378-387.</Citation><ArticleIdList><ArticleId IdType="pubmed">11553846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota, T., N. Yokosawa, S. Yokota, and N. Fujii. 2001. C-terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem. Biophys. Res. Commun. 283:255-259.</Citation><ArticleIdList><ArticleId IdType="pubmed">11322797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane, I., and F. A. Ennis. 1987. Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes. J. Exp. Med. 166:999-1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2188728</ArticleId><ArticleId IdType="pubmed">3116147</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.</Citation><ArticleIdList><ArticleId IdType="pubmed">11439948</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard, G. T., and G. C. Sen. 1996. Effects of adenovirus E1A protein on interferon-signaling. Virology 224:25-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">8862396</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy, D. E., and A. Garcia-Sastre. 2001. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12:143-156.</Citation><ArticleIdList><ArticleId IdType="pubmed">11325598</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S., S. Labrecque, M. C. Gauzzi, A. R. Cuddihy, A. H. Wong, S. Pellegrini, G. J. Matlashewski, and A. E. Koromilas. 1999. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727-5737.</Citation><ArticleIdList><ArticleId IdType="pubmed">10523853</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao, C. L., Y. L. Lin, J. J. Wang, Y. L. Huang, C. T. Yeh, S. H. Ma, and L. K. Chen. 1997. Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells. J. Virol. 71:5963-5971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191852</ArticleId><ArticleId IdType="pubmed">9223486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, Y. L., C. L. Liao, L. K. Chen, C. T. Yeh, C. I. Liu, S. H. Ma, Y. Y. Huang, Y. L. Huang, C. L. Kao, and C. C. King. 1998. Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 72:9729-9737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110483</ArticleId><ArticleId IdType="pubmed">9811707</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach, B. D., and C. M. Rice. 2001. Flaviviridae: the viruses and their replication, p. 991-1041. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott/The Williams &amp; Wilkins Co., Philadelphia, Pa.</Citation></Reference><Reference><Citation>Look, D. C., W. T. Roswit, A. G. Frick, Y. Gris-Alevy, D. M. Dickhaus, M. J. Walter, and M. J. Holtzman. 1998. Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871-880.</Citation><ArticleIdList><ArticleId IdType="pubmed">9881977</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingam, S., J. Meanger, P. S. Foster, and B. A. Lidbury. 2002. The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses. J. Leukoc. Biol. 72:429-439.</Citation><ArticleIdList><ArticleId IdType="pubmed">12223509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashimo, T., M. Lucas, D. Simon-Chazottes, M. P. Frenkiel, X. Montagutelli, P. E. Ceccaldi, V. Deubel, J. L. Guenet, and P. Despres. 2002. A nonsense mutation in the gene encoding 2&#x2032;-5&#x2032;-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. USA 99:11311-11316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC123253</ArticleId><ArticleId IdType="pubmed">12186974</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, D. M., B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin, J. W. Waldman, and D. D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212176</ArticleId><ArticleId IdType="pubmed">9480977</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, D. M., Y. Zhang, B. M. Rahill, W. J. Waldman, and D. D. Sedmak. 1999. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J. Immunol. 162:6107-6113.</Citation><ArticleIdList><ArticleId IdType="pubmed">10229853</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan, J. L., G. G. Sanchez-Burgos, M. Laurent-Rolle, and A. Garcia-Sastre. 2003. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 100:14333-14338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283592</ArticleId><ArticleId IdType="pubmed">14612562</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishio, M., M. Tsurudome, M. Ito, M. Kawano, H. Komada, and Y. Ito. 2001. High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons. J. Virol. 75:9165-9176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114485</ArticleId><ArticleId IdType="pubmed">11533180</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisien, J. P., J. F. Lau, J. J. Rodriguez, B. M. Sullivan, A. Moscona, G. D. Parks, R. A. Lamb, and C. M. Horvath. 2001. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283:230-239.</Citation><ArticleIdList><ArticleId IdType="pubmed">11336548</ArticleId></ArticleIdList></Reference><Reference><Citation>Perelygin, A. A., S. V. Scherbik, I. B. Zhulin, B. M. Stockman, Y. Li, and M. A. Brinton. 2002. Positional cloning of the murine flavivirus resistance gene. Proc. Natl. Acad. Sci. USA 99:9322-9327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC123139</ArticleId><ArticleId IdType="pubmed">12080145</ArticleId></ArticleIdList></Reference><Reference><Citation>Petricoin, E., III, M. David, K. Igarashi, C. Benjamin, L. Ling, S. Goelz, D. S. Finbloom, and A. C. Larner. 1996. Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase. Mol. Cell. Biol. 16:1419-1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231126</ArticleId><ArticleId IdType="pubmed">8657115</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89003</ArticleId><ArticleId IdType="pubmed">11585785</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweizer, M., and E. Peterhans. 2001. Noncytopathic bovine viral diarrhea virus inhibits double-stranded RNA-induced apoptosis and interferon synthesis. J. Virol. 75:4692-4698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114223</ArticleId><ArticleId IdType="pubmed">11312340</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.</Citation><ArticleIdList><ArticleId IdType="pubmed">11544356</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon, T., N. M. Dung, B. Wills, R. Kneen, M. Gainsborough, T. V. Diet, T. T. Thuy, H. T. Loan, V. C. Khanh, D. W. Vaughn, N. J. White, and J. J. Farrar. 2003. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 361:821-826.</Citation><ArticleIdList><ArticleId IdType="pubmed">12642049</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon, T., H. Ni, D. W. Beasley, M. Ekkelenkamp, M. J. Cardosa, and A. D. Barrett. 2003. Origin and evolution of Japanese encephalitis virus in southeast Asia. J. Virol. 77:3091-3098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC149749</ArticleId><ArticleId IdType="pubmed">12584335</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.</Citation><ArticleIdList><ArticleId IdType="pubmed">9759489</ArticleId></ArticleIdList></Reference><Reference><Citation>Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551-560.</Citation><ArticleIdList><ArticleId IdType="pubmed">7758109</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, S. L., and M. G. Katze. 2001. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 284:1-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">11352662</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber, and M. M. Lai. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.</Citation><ArticleIdList><ArticleId IdType="pubmed">10390359</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, J. L., C. Schoenherr, and S. E. Grossberg. 1980. Protection against Japanese encephalitis virus in mice and hamsters by treatment with carboxymethylacridanone, a potent interferon inducer. J. Infect. Dis. 142:394-399.</Citation><ArticleIdList><ArticleId IdType="pubmed">6255036</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton, C., K. Mossman, and G. McFadden. 1992. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258:1369-1372.</Citation><ArticleIdList><ArticleId IdType="pubmed">1455233</ArticleId></ArticleIdList></Reference><Reference><Citation>Urosevic, N. 2003. Is flavivirus resistance interferon type I-independent? Immunol. Cell Biol. 81:224-229.</Citation><ArticleIdList><ArticleId IdType="pubmed">12752687</ArticleId></ArticleIdList></Reference><Reference><Citation>Vithanomsat, S., C. Wasi, C. Harinasuta, and P. Thongcharoen. 1984. The effect of interferon on flaviviruses in vitro: a preliminary study. Southeast Asian J. Trop. Med. Public Health 15:27-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">6330910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, S. F., C. J. Lee, C. L. Liao, R. A. Dwek, N. Zitzmann, and Y. L. Lin. 2002. Antiviral effects of an iminosugar derivative on flavivirus infections. J. Virol. 76:3596-3604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136089</ArticleId><ArticleId IdType="pubmed">11907199</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota, S., N. Yokosawa, T. Kubota, T. Suzutani, I. Yoshida, S. Miura, K. Jimbow, and N. Fujii. 2001. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology 286:119-124.</Citation><ArticleIdList><ArticleId IdType="pubmed">11448165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. J., U. Vinkemeier, W. Gu, D. Chakravarti, C. M. Horvath, and J. E. Darnell, Jr. 1996. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA 93:15092-15096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26361</ArticleId><ArticleId IdType="pubmed">8986769</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>